Primary CNS Lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Diagnosis; Objective RespOnse; THErApy
Condition: Primary Central Neurvous System Lymphoma (PCNSL) Intervention: Procedure: Lumbar puncture Sponsors: IRCCS San Raffaele; Teresa Calimeri; Sara Steffanoni Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2021 Category: Research Source Type: clinical trials
A Dose-escalating Pilot Study of Orelabrutinib for Newly-diagnosed PCNSL
Condition: Primary Central Nervous System Lymphoma Interventions: Drug: Orelabrutinib; Drug: Rituximab; Drug: Methotrexate (MTX); Drug: Dexamethasone Sponsor: Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2021 Category: Research Source Type: clinical trials
